
FDA Okays Rexulti for Agitation in Alzheimer’s
The US Food and Drug Administration has announced the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s. Learn more.